455 related articles for article (PubMed ID: 27877038)
1. Sulfonate-modified phenylboronic acid-rich nanoparticles as a novel mucoadhesive drug delivery system for vaginal administration of protein therapeutics: improved stability, mucin-dependent release and effective intravaginal placement.
Li C; Huang Z; Liu Z; Ci L; Liu Z; Liu Y; Yan X; Lu W
Int J Nanomedicine; 2016; 11():5917-5930. PubMed ID: 27877038
[TBL] [Abstract][Full Text] [Related]
2. Mucin-controlled drug release from mucoadhesive phenylboronic acid-rich nanoparticles.
Li C; Liu Z; Yan X; Lu W; Liu Y
Int J Pharm; 2015 Feb; 479(1):261-4. PubMed ID: 25528296
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of mucoadhesive nanoparticles of poly (methyl vinyl ether-co-maleic anhydride) containing glycyrrhizic acid intended for vaginal administration.
Aguilar-Rosas I; Alcalá-Alcalá S; Llera-Rojas V; Ganem-Rondero A
Drug Dev Ind Pharm; 2015; 41(10):1632-9. PubMed ID: 25391332
[TBL] [Abstract][Full Text] [Related]
4. Insulin-loaded mucoadhesive nanoparticles based on mucin-chitosan complexes for oral delivery and diabetes treatment.
Mumuni MA; Kenechukwu FC; Ofokansi KC; Attama AA; Díaz DD
Carbohydr Polym; 2020 Feb; 229():115506. PubMed ID: 31826394
[TBL] [Abstract][Full Text] [Related]
5. Enhancing Stability and Mucoadhesive Properties of Chitosan Nanoparticles by Surface Modification with Sodium Alginate and Polyethylene Glycol for Potential Oral Mucosa Vaccine Delivery.
Amin MK; Boateng JS
Mar Drugs; 2022 Feb; 20(3):. PubMed ID: 35323455
[No Abstract] [Full Text] [Related]
6. Development and in vitro evaluation of a mucoadhesive vaginal delivery system for nystatin.
Hombach J; Palmberger TF; Bernkop-Schnürch A
J Pharm Sci; 2009 Feb; 98(2):555-64. PubMed ID: 18563796
[TBL] [Abstract][Full Text] [Related]
7. Mucoadhesive nanoliposomal formulation for vaginal delivery of an antifungal.
Karimunnisa S; Atmaram P
Drug Dev Ind Pharm; 2013 Sep; 39(9):1328-37. PubMed ID: 22866766
[TBL] [Abstract][Full Text] [Related]
8. Development of a mucoadhesive delivery system for control release of doxepin with application in vaginal pain relief associated with gynecological surgery.
Sanz R; Clares B; Mallandrich M; Suñer-Carbó J; Montes MJ; Calpena AC
Int J Pharm; 2018 Jan; 535(1-2):393-401. PubMed ID: 29146542
[TBL] [Abstract][Full Text] [Related]
9. Development of mucoadhesive drug delivery system using phenylboronic acid functionalized poly(D,L-lactide)-b-dextran nanoparticles.
Liu S; Jones L; Gu FX
Macromol Biosci; 2012 Dec; 12(12):1622-6. PubMed ID: 23165800
[TBL] [Abstract][Full Text] [Related]
10. Vaginal Delivery of Benzydamine Hydrochloride through Liposomes Dispersed in Mucoadhesive Gels.
Tuğcu-Demiröz F
Chem Pharm Bull (Tokyo); 2017 Jul; 65(7):660-667. PubMed ID: 28442642
[TBL] [Abstract][Full Text] [Related]
11. Phenylboronic acid-tethered chondroitin sulfate-based mucoadhesive nanostructured lipid carriers for the treatment of dry eye syndrome.
Tan G; Li J; Song Y; Yu Y; Liu D; Pan W
Acta Biomater; 2019 Nov; 99():350-362. PubMed ID: 31449929
[TBL] [Abstract][Full Text] [Related]
12. Development of starch based mucoadhesive vaginal drug delivery systems for application in veterinary medicine.
Gök MK; Özgümüş S; Demir K; Cirit Ü; Pabuccuoğlu S; Cevher E; Özsoy Y; Bacınoğlu S
Carbohydr Polym; 2016 Jan; 136():63-70. PubMed ID: 26572329
[TBL] [Abstract][Full Text] [Related]
13. Vaginal residence and pharmacokinetic preclinical study of topical vaginal mucoadhesive W/S emulsions containing ciprofloxacin.
Campaña-Seoane M; Pérez-Gago A; Vázquez G; Conde N; González P; Martinez A; Martínez X; García Varela L; Herranz M; Aguiar P; Fernández-Ferreiro A; Laguna R; Otero-Espinar FJ
Int J Pharm; 2019 Jan; 554():276-283. PubMed ID: 30423417
[TBL] [Abstract][Full Text] [Related]
14. Design and Characterization of Mucoadhesive Gelatin-Ethylcellulose Microparticles for the Delivery of Curcumin to the Bladder.
Oliveira MB; da Silva JB; Montanha MC; Kimura E; Diniz A; Bruschi ML
Curr Drug Deliv; 2018; 15(8):1112-1122. PubMed ID: 29732969
[TBL] [Abstract][Full Text] [Related]
15. Phenylboronic acid-functionalized glycopolymeric nanoparticles for biomacromolecules delivery across nasal respiratory.
Zhang X; Wang Y; Zheng C; Li C
Eur J Pharm Biopharm; 2012 Sep; 82(1):76-84. PubMed ID: 22659236
[TBL] [Abstract][Full Text] [Related]
16. Effect of mucoadhesive polymers on the in vitro performance of insulin-loaded silica nanoparticles: Interactions with mucin and biomembrane models.
Andreani T; Miziara L; Lorenzón EN; de Souza AL; Kiill CP; Fangueiro JF; Garcia ML; Gremião PD; Silva AM; Souto EB
Eur J Pharm Biopharm; 2015 Jun; 93():118-26. PubMed ID: 25843239
[TBL] [Abstract][Full Text] [Related]
17. Mucoadhesive and enzymatic inhibitory nanoparticles for transnasal insulin delivery.
Wang Y; Zhang X; Cheng C; Li C
Nanomedicine (Lond); 2014 Apr; 9(4):451-64. PubMed ID: 24910876
[TBL] [Abstract][Full Text] [Related]
18. Chitosan in mucoadhesive drug delivery: focus on local vaginal therapy.
Andersen T; Bleher S; Eide Flaten G; Tho I; Mattsson S; Škalko-Basnet N
Mar Drugs; 2015 Jan; 13(1):222-36. PubMed ID: 25574737
[TBL] [Abstract][Full Text] [Related]
19. Mucoadhesive liposomes as new formulation for vaginal delivery of curcumin.
Berginc K; Suljaković S; Škalko-Basnet N; Kristl A
Eur J Pharm Biopharm; 2014 May; 87(1):40-6. PubMed ID: 24534774
[TBL] [Abstract][Full Text] [Related]
20. Chitosan gels for the vaginal delivery of lactic acid: relevance of formulation parameters to mucoadhesion and release mechanisms.
Bonferoni MC; Giunchedi P; Scalia S; Rossi S; Sandri G; Caramella C
AAPS PharmSciTech; 2006; 7(4):104. PubMed ID: 17285750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
